Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-707-7 | CAS number: 124-64-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Additional information
No data are available on fertility effects for THPC.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Dose descriptor:
- NOAEL
Additional information
Developmental effects of THPC have been assessed through one OECD 414 study (Clark, 1992), under GLP.
Summary of key information on THPC
Range-finding study
In a range finding teratogenicity study in rabbits, maternal animals were given 0, 4.8, 14.4 or 48 mg Active Ingredient (AI)/kg bw/day. Maternal effects were noted at 14.4 and 48 mg AI/kg bw/day and included reduced body weight gain and food consumption. Each foetus was subjected to external observation and a tissue examination was carried out on foetuses exhibiting malformations and on one control litter. Mean foetal and litter weights were decreased at 14.4 and 48 mg AI/kg bw/day. At 48 mg/kg bw/day, eye and limb malformations were observed in foetuses from all litters. No treatment-related malformations were seen at 6 and 14.4 mg AI/kg bw/day. As eye and limb malformations were observed at maternal toxic doses, it was considered that these findings were secondary non-specific effects.
Main study
In a teratogenicity study in rabbits, maternal animals were given 0, 1.6, 4.8, 14.4 or 28.8 mg AI/kg bw/day. Maternal effects were noted at 4.8, 14.4 and 28.8 mg AI/kg bw/day and included reduced food consumption and body weight gain. At 28.8 mg AI/kg bw/day, one female aborted and was killed; one female died during the study. In addition, two high dose females appeared not to be pregnant, resulting in 11 pregnant animals at the end of the study, versus 15/16 pregnant animals in the other dose groups.
No changes in mean litter or foetal weight were observed. An increased incidence of foetuses with slightly lower insertion of the pelvic girdle was noted at 4.8, 14.4 and 28.8 mg AI/kg bw/day. An increase in supernumerary ribs was noted in foetuses at 28.8 mg AI/kg bw/day. No clear teratogenic changes were noted in any dose level, with the exception of 3 foetuses with microphthalmia at 28.8 mg AI/kg bw/day. All three foetuses were from one litter; the maternal animal showed slight effects on body weight gain or food consumption, but with no specific clinical signs.
The maternal and developmental NOAEL are set at 1.6 mg AI/kg bw/day, based on decreased body weight and food consumption in maternal animals and an increased incidence of foetuses with slightly lower insertion of the pelvic girdle.
Eye and limb malformations were noted at the high dose level in which maternal toxicity was seen in the rabbit. We believe that maternal toxicity as measured by food consumption and body weight in this study was likely underestimated because repeated dose toxicity studies in rats revealed significant liver toxicity at similar or lower dose levels.
Indeed, animals of the 90-day toxicity rat study showed also liver toxic effects at lower dose levels (i.e. 15 mg/kg/day) compared to doses selected for the teratology studies. Given the important role of the liver ensuring the maternal homeostasis, the possible influence of the hepatotoxic effect of THPC deserves further investigation. This indicates that the observed developmental effect could be secondary to hepatotoxic effects. In public literature, other substances showing similar eye and limb malformations were identified (cyanazine, 2,4-dichlorophenoxyacetic acid and flurprimodol are examples). These effects were only observed in excess of maternal toxicity and were assessed not to be a proven direct effect of the test substance.
THPC is corrosive to the skin following topical administration in rabbits. Similar effects occurred during the gavage application of the test substance in the rabbit teratology study. This effect might not always have been detected due to the post treatment period and the rapid renewal capability of the intestinal tract. This irritation might have affected intestinal function and combined with the reduced food intake might have resulted in a low absorption of nutrients critical to the foetus. These observations suggest that maternal toxicity is the main driver of these abnormalities.
Therefore, additional experiments are proposed with another substance from the same THP+ family member (see note below) to elucidate how secondary non-specific effects are occurring. Indeed Solvay is currently building a research project to consolidate the supporting evidence. In addition, there is a clear toxicological threshold for the developmental effect, below which no effects would be expected. It was concluded that THPC should be classified for reproductive toxicity as Category 2 -Suspected of damaging fertility or the unborn child (H361d -Suspected of damaging fertility or the unborn child), according to CLP regulation (No) 1272/2008.
Note: Information from other THP+ salts is judged relevant because as an ionic salt THPC is completely dissociated into THP+ and Cl- in aqueous solutions and the equivalent is true for most of the THP+ salts, including sulphate salt. As a consequence hazard properties evaluated in aqueous solution could reasonably be predicted using data from the equivalent sulphate salt. Therefore a read-across approach could be done for certain hazard properties between THPC (chloride salt) and other THP+ salts.
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.